Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
MOBILion Expands into Proteomics MS Market
MOBILion Systems set out in 2015 to disrupt the LC-MS market. The company’s Structures for Lossless Ion Manipulation (SLIM)technology utilizes a printed circuit board and electrical fields to move ions along what the company describes as a “serpentine path,” replacing the shorter straight ion flight path found in other high-resolution IMS systems. Because the ions […]
Carterra Introduces Faster SPR
At the Society for Lab Automation and Screening (SLAS) 2026, Carterra introduced its latest surface plasmon resonance (SPR) system, the Carterra Vega High-Throughput Surface Plasmon Resonance (HT-SPR) instrument. The system will expand the company’s presence into primary screening, one of the first stages of drug discovery, in addition to secondary screening, where SPR has traditionally […]
New Report Details Higher Education Science R&D Spending
According to a report from the National Science Foundation published this month, in FY24 (ending September 30, 2024), overall R&D spending (science and engineering and non-science and engineering) by US higher education institutions grew 8.1% to $117,719 million. The federal government was the leading source of spending. But spending growth was the fastest for state […]
The Trials and Tribulations of the US Academic and Government End-Market in 2025: Presentation Highlights from the 44th JPMorgan Healthcare Conference
On February 7, 2025, the Trump administration announced a 15% cap on all indirect costs for new and existing NIH grants. However, on April 4, 2025, the US District Court in Massachusetts enacted a preliminary injunction blocking the limit. In response, the HHS appealed the injunction to the US Court of Appeals for the First […]
Single Use Leads Bioreactor Market Growth
A new report from Strategic Directions International (SDi), a business intelligence firm specializing in the analytical instrument market, finds that the compound annual growth rate (CAGR) between 2024 and 2029 of demand in the cell and gene therapy (C>) market for seven categories of analytical technologies will expand in the high single digits. The technologies […]